Adenylosuccinate lyase deficiency
Adenylosuccinate lyase deficiency is a rare metabolic disorder that primarily affects the nervous system. This condition is characterized by a deficiency of the enzyme adenylosuccinate lyase, which is involved in the purine synthesis pathway.
Symptoms[edit | edit source]
The symptoms of adenylosuccinate lyase deficiency can vary widely, even among members of the same family. They can include developmental delay, intellectual disability, seizures, and autism spectrum disorder. Some affected individuals may also have distinctive facial features, such as a broad forehead, low-set ears, and a small chin.
Causes[edit | edit source]
Adenylosuccinate lyase deficiency is caused by mutations in the ADSL gene. This gene provides instructions for making the enzyme adenylosuccinate lyase, which is involved in the production of purines. Purines are key components of DNA, RNA, and molecules such as ATP and GTP that serve as energy sources in the cell.
Diagnosis[edit | edit source]
Diagnosis of adenylosuccinate lyase deficiency is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests can include biochemical tests to measure the levels of certain substances in the body, genetic testing to identify mutations in the ADSL gene, and neuroimaging studies to evaluate the structure and function of the brain.
Treatment[edit | edit source]
There is currently no cure for adenylosuccinate lyase deficiency, and treatment is symptomatic and supportive. This can include medications to manage seizures, physical and occupational therapy to improve motor skills and coordination, and special education services to address developmental delays and learning disabilities.
Prognosis[edit | edit source]
The prognosis for individuals with adenylosuccinate lyase deficiency varies depending on the severity of symptoms. Some individuals may have a relatively mild course with few neurological problems, while others may experience severe developmental delay and other serious complications.
See also[edit | edit source]
This metabolic pathology-related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD